OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Special considerations for evaluating psilocybin-facilitated psychotherapy in vulnerable populations
Cynthia E. Ortiz, Haley Maria Dourron, Noah W Sweat, et al.
Neuropharmacology (2022) Vol. 214, pp. 109127-109127
Open Access | Times Cited: 15
Cynthia E. Ortiz, Haley Maria Dourron, Noah W Sweat, et al.
Neuropharmacology (2022) Vol. 214, pp. 109127-109127
Open Access | Times Cited: 15
Showing 15 citing articles:
A Systematic Review of Participant Diversity in Psychedelic-Assisted Psychotherapy Trials
Stephanie L. Haft, Amanda E. Downey, Marissa Raymond‐Flesch, et al.
Psychiatry Research (2025) Vol. 345, pp. 116359-116359
Open Access | Times Cited: 3
Stephanie L. Haft, Amanda E. Downey, Marissa Raymond‐Flesch, et al.
Psychiatry Research (2025) Vol. 345, pp. 116359-116359
Open Access | Times Cited: 3
Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020
Emma I Kopra, Jason Ferris, Adam Winstock, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 7, pp. 733-748
Open Access | Times Cited: 32
Emma I Kopra, Jason Ferris, Adam Winstock, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 7, pp. 733-748
Open Access | Times Cited: 32
Psychedelics: Threshold of a Therapeutic Revolution
David J. Heal, Sharon L. Smith, Sean J. Belouin, et al.
Neuropharmacology (2023) Vol. 236, pp. 109610-109610
Open Access | Times Cited: 25
David J. Heal, Sharon L. Smith, Sean J. Belouin, et al.
Neuropharmacology (2023) Vol. 236, pp. 109610-109610
Open Access | Times Cited: 25
Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs
Farah Zia, Michael H. Baumann, Sean J. Belouin, et al.
Neuropharmacology (2023) Vol. 233, pp. 109528-109528
Open Access | Times Cited: 20
Farah Zia, Michael H. Baumann, Sean J. Belouin, et al.
Neuropharmacology (2023) Vol. 233, pp. 109528-109528
Open Access | Times Cited: 20
Psilocybin for the treatment of Alzheimer’s disease
Siyi Zheng, Rong Ma, Yang Yang, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 5
Siyi Zheng, Rong Ma, Yang Yang, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 5
Practical considerations in the establishment of psychedelic research programs
Brian S. Barnett, M. Frances Vest, Marcus S. Delatte, et al.
Psychopharmacology (2024)
Open Access | Times Cited: 3
Brian S. Barnett, M. Frances Vest, Marcus S. Delatte, et al.
Psychopharmacology (2024)
Open Access | Times Cited: 3
Classic psychedelics, health behavior, and physical health
Otto Simonsson, Peter S. Hendricks, Richard Chambers, et al.
Therapeutic Advances in Psychopharmacology (2022) Vol. 12
Open Access | Times Cited: 16
Otto Simonsson, Peter S. Hendricks, Richard Chambers, et al.
Therapeutic Advances in Psychopharmacology (2022) Vol. 12
Open Access | Times Cited: 16
Psychedelic Microdosing among Young Adults from Southern California
Alyssa F. Harlow, Peter S. Hendricks, Adam M. Leventhal, et al.
Journal of Psychoactive Drugs (2024), pp. 1-12
Closed Access | Times Cited: 3
Alyssa F. Harlow, Peter S. Hendricks, Adam M. Leventhal, et al.
Journal of Psychoactive Drugs (2024), pp. 1-12
Closed Access | Times Cited: 3
The library is open: a scoping review on queer representation in psychedelic research
Amy Bartlett, Challian Christ, Bradford Martins, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 1
Amy Bartlett, Challian Christ, Bradford Martins, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 1
The Elephant in the Room: Personal Use of Psychedelics Among Psychedelic Researchers
Peter S. Hendricks, Charles D. Nichols
Psychedelic Medicine (2023) Vol. 1, Iss. 3, pp. 122-123
Closed Access | Times Cited: 3
Peter S. Hendricks, Charles D. Nichols
Psychedelic Medicine (2023) Vol. 1, Iss. 3, pp. 122-123
Closed Access | Times Cited: 3
Adapting psychedelic medicine for headache and chronic pain disorders
Emmanuelle A. D. Schindler, Peter S. Hendricks
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 10, pp. 867-882
Closed Access | Times Cited: 2
Emmanuelle A. D. Schindler, Peter S. Hendricks
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 10, pp. 867-882
Closed Access | Times Cited: 2
Dedication: Roland R. Griffiths (July 19, 1946–October 16, 2023)
Jack E. Henningfield, Sean J. Belouin
Neuropharmacology (2024) Vol. 252, pp. 109945-109945
Open Access
Jack E. Henningfield, Sean J. Belouin
Neuropharmacology (2024) Vol. 252, pp. 109945-109945
Open Access
Psychedelic-Assisted Therapy Training: An Argument in Support of Firsthand Experience of Nonordinary States of Consciousness in the Development of Competence
Shannon Dames, Crosbie Watler, Pamela Kryskow, et al.
Psychedelic Medicine (2024) Vol. 2, Iss. 3, pp. 130-137
Closed Access
Shannon Dames, Crosbie Watler, Pamela Kryskow, et al.
Psychedelic Medicine (2024) Vol. 2, Iss. 3, pp. 130-137
Closed Access
A Systematic Review of Participant Diversity in Psychedelic-Assisted Psychotherapy Trials
Stephanie L. Haft, Amanda E. Downey, Marissa Reymond-Flesch, et al.
(2024)
Open Access
Stephanie L. Haft, Amanda E. Downey, Marissa Reymond-Flesch, et al.
(2024)
Open Access
Therapeutic Potential of MDMA- and Psychedelic-Assisted Psychotherapy for Adolescent Depression and Trauma
Jamarie Geller, Eric Whitney
Current Psychiatry Reports (2024)
Closed Access
Jamarie Geller, Eric Whitney
Current Psychiatry Reports (2024)
Closed Access
